Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques?

Subjects

Subjects :

Atherosclerosis immunology
Atherosclerosis pathology
Humans
Plaque, Atherosclerotic immunology
Plaque, Atherosclerotic pathology
Programmed Cell Death 1 Receptor immunology
Atherosclerosis drug therapy
Nivolumab therapeutic use
Plaque, Atherosclerotic drug therapy
Programmed Cell Death 1 Receptor antagonists & inhibitors

Details

Language :

English

ISSN :

1569-8041

Volume :

29

Issue :

1

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Academic Journal

Accession number :

29106493

Full Text :

https://doi.org/10.1093/annonc/mdx718